AbbVie 'Concocted' Cancer Drug IP Claims, Biotech Firm Says
By Ben Adlin · August 28, 2026, 9:27 PM EDT
Biotech firms ProfoundBio and Genmab urged a Seattle federal judge Thursday to throw out rival AbbVie's lawsuit accusing two of its former employees of taking trade secrets on cancer therapies to...
To view the full article, register now.